Risk communication AC meeting
This article was originally published in The Tan Sheet
FDA will hold a public meeting of the Risk Communication Advisory Committee on Feb. 28 and 29 at the Washington, D.C. North/Gaithersburg, Md. Hilton, the agency announces in a Feb. 8 Federal Register notice. The committee will meet the first day from 8 a.m. to 5 p.m. for presentations and discussion of the relation of the agency's risk communication programs and FDA's responsibilities. The committee will continue on the second day from 8 a.m. to 4 p.m. with presentations and discussion of FDA's proposed template for product recall press releases, the agency says...
You may also be interested in...
Shortly after wrapping up a Phase III trial for its proposed generic Advair Diskus product in the US, Cipla has won FDA approval for the first generic Proventil HFA product, as it continues to build up steam in the US respiratory market.
The UK's MHRA is looking for manufacturers to submit COVID-19 self-tests that meet minimum and desired criteria for evaluation, after finding its recently purchased 3.5m self-tests failed to meet these standards. Criteria include no requirement for testing knowledge or training or assistance from a healthcare professional in administering or interpreting the results of the test, as well as a 95% accuracy level.
Henlius has struck a deal with Mabxience to market its HLX02 trastuzumab biosimilar in Argentina, Uruguay and Paraguay.